Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201

Autor: Kretzer C, Jordan PM, Bilancia R, Rossi A, Gür Maz T, Banoglu E, Schubert US, Werz O

Publikováno v: Journal of Inflammation Research, Vol Volume 15, Pp 911-925 (2022)

Christian Kretzer,1 Paul M Jordan,1 Rossella Bilancia,2 Antonietta Rossi,2 Tuğçe Gür Maz,3 Erden Banoglu,3 Ulrich S Schubert,4,5 Oliver Werz1,5 1Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller Univ

Externí odkaz: https://doaj.org/article/b3ecd5eda8994a72b8376cc40a101da2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Optimisation by Design of Experiment of Benzimidazol-2-One Synthesis under Flow Conditions.

Autor: Mostarda S; Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy.; Current affiliation: Novartis Pharma AG, CH-4002 Basel, Switzerland., Gür Maz T; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Etiler, 06560 Ankara, Turkey., Piccinno A; Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy., Cerra B; Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy. bruno.cerra@chimfarm.unipg.it., Banoglu E; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Etiler, 06560 Ankara, Turkey. banoglu@gazi.edu.tr.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2019 Jul 03; Vol. 24 (13). Date of Electronic Publication: 2019 Jul 03.